Blog Rank
September 29, 2012 | Comments Off on Blog Rank
Positive on United Therapeutics – Analyst BlogNASDAQWe recently reiterated our Outperform recommendation on United Therapeutics ( UTHR ), which carries a Zacks #2 Rank (short-term Buy rating). United Therapeutics started 2012 on a strong note with first quarter earnings coming in well above expectations.